Stunner's new adeno-associated virus (AAV) application provides researchers with a full readout of how many AAV capsids they have, how many capsids are packed with DNA, and if there is any aggregation. This can be achieved in less than one minute and with only 2 µL of sample.

Stunner pulls together ultraviolet-visible concentration from the sample and measures the total protein and DNA in it. Dynamic light scattering identifies AAV capsids based on their size and checks for aggregation. Stunner then combines all the information measured to provide an accurate titer and empty/full ratio.

Bio-Techne opens GMP manufacturing facility
Bio-Techne has opened a 61,000-sq-ft good manufacturing practice (GMP) manufacturing facility in St. Paul, MN. The space will be dedicated to large-scale...

CRB introduces multimodal facility to support cell & gene therapy clients
CRB has created SlateXpace, a multimodal manufacturing facility solution to support complex therapeutic product pipelines.

Irvine Scientific to exclusively distribute stem cell tech
Fujifilm Irvine Scientific said it has become the exclusive worldwide distributor of cellnest, a recombinant peptide attachment substrate that's designed...

Amarna Therapeutics, FPS examine gene therapy platform
Amarna Therapeutics will collaborate with scientists from Progreso y Salud Foundation (FPS) of Spain to jointly examine the efficacy of Amarna's Svec...

Bio-Techne rebrands genome engineering as part of R&D Systems portfolio
Bio-Techne has rebranded its cell and gene engineering product offer as part of its R&D Systems biotechnology brand.